Medivizor

Title of notification

Here comes the notification
X
 
icon
icon
hodgkin's lymphoma | Research | Treatment | 10 pages | source: Journal of clinical oncology | Added Sep 17, 2023

Evaluating the long-term effectiveness and safety of nivolumab and AVD chemotherapy combination in patients with early-stage unfavorable classical Hodgkin lymphoma.

This study reported the long-term safety and effectiveness of nivolumab (Opdivo; N) + AVD (doxorubicin, vinblastine, and dacarbazine) chemotherapy combinations in patients with early-stage unfavorable classical Hodgkin lymphoma (cHL). The data showed that the N+AVD combination is safe and highly effective over the long term for these patients.

icon
icon
prostate cancer | Research | Treatment | 10 pages | source: JAMA network open | Added Sep 17, 2023

Does statin use improve survival outcomes in men with advanced prostate cancer undergoing androgen deprivation therapy?

This study evaluated the association between statin (cholesterol-lowering drugs) use and survival outcomes in men with advanced prostate cancer (PC) undergoing androgen deprivation therapy (ADT). The data showed that statin use improved the survival outcomes in these patients.

icon
icon
hodgkin's lymphoma | Research | Treatment | 10 pages | source: The Lancet. Haematology | Added Aug 27, 2023

Evaluating the effectiveness and safety of brentuximab vedotin plus nivolumab consolidation therapy after autologous hematopoietic stem-cell transplantation in patients with high-risk classic Hodgkin lymphoma.

This study evaluated the effectiveness and safety of brentuximab vedotin (BV; Adcetris) plus nivolumab (Opdivo) consolidation therapy after autologous hematopoietic stem-cell transplantation (HSCT) in patients with high-risk relapsed or refractory (r/r) classical Hodgkin lymphoma (cHL). The data showed that the BV plus nivolumab combination was effective with manageable side effects in these patients.

icon
icon
erectile dysfunction | Research | Treatment | 10 pages | source: Urology | Added Aug 27, 2023

Evaluating the effectiveness and safety of platelet rich plasma for the treatment of erectile dysfunction.

This study evaluated the effectiveness and safety of platelet-rich plasma (PRP) injections for the treatment of patients with mild and moderate erectile dysfunction (ED). The data showed that PRP was a safe and promising treatment for improving mild to moderate ED.

icon
icon
benign prostatic hyperplasia | Research | Treatment | 10 pages | source: Investigative and clinical urology | Added Aug 27, 2023

Evaluating the effectiveness and safety of Quisqualis indica extract for the treatment of patients with lower urinary tract symptoms.

This study evaluated the effectiveness and safety of Quisqualis indica (Rangoon creeper or Chinese honeysuckle; a type of plant) extract for the treatment of patients with lower urinary tract symptoms (LUTS). The data showed that Quisqualis indica extract was safe and effective for the treatment of these patients.

icon
icon
icon
parkinson's disease | Research | Treatment | Lifestyle | 10 pages | source: BMJ Open | Added Jul 30, 2023

Evaluating the effects of Baduanjin exercise on motor function, balance, and gait in patients with Parkinson’s disease.

This study evaluated the effects of Baduanjin exercise on motor function, balance, and gait in patients with Parkinson’s disease (PD). The data showed that Baduanjin exercise significantly improved motor function, balance, and gait in these patients.

icon
icon
infertility & reproductive technologies | Research | Treatment | 10 pages | source: The world journal of men's health | Added Jul 30, 2023

Evaluating the effect of varicocele repair on sperm parameters in infertile men.

This study evaluated the effect of varicocele repair (VR) on sperm parameters in infertile men with clinical varicocele. The data showed that VR significantly increased the total sperm count, sperm motility (movement), morphology (shape), and concentration in these men.

icon
icon
diabetes mellitus | Research | Lifestyle | 10 pages | source: Frontiers in Endocrinology | Added Jul 02, 2023

Which type of aerobic training provides greater benefits to patients with type 2 diabetes?

This study examined the impact of three types of aerobic training exercises on measurements of heart and metabolic function in patients with type 2 diabetes (T2D). The data showed that greater improvements occurred in heart and breathing function measurements with low-volume high-intensity training (HITT) compared to low-volume moderate to vigorous intensity continuous training (MICT) in these patients.

icon
icon
coronary artery disease | Research | Treatment | 10 pages | source: Circulation | Added Jul 02, 2023

Evaluating the effectiveness and safety of indobufen plus clopidogrel versus aspirin plus clopidogrel in patients with negative cardiac troponin undergoing percutaneous coronary intervention with drug-eluting stent.

This study evaluated the effectiveness and safety of indobufen (Ibustrin) plus clopidogrel (Plavix) versus aspirin plus clopidogrel in patients with negative cardiac troponin undergoing percutaneous coronary intervention (PCI) with drug-eluting stent (DES). The data showed that indobufen plus clopidogrel significantly reduced the risk of bleeding events without increasing the risk of heart attacks, stroke, or death events compared with aspirin plus clopidogrel in these patients.

icon
icon
diabetes mellitus | Research | Treatment | 10 pages | source: Journal of Diabetes and its Complications | Added Jun 11, 2023

Can new glucose-lowering medications influence stroke risk in patients with type 2 diabetes?

This review assessed the effects of new glucose-lowering drugs on stroke risk in patients with type 2 diabetes (T2D). The study showed that glucagon-like peptide-1 receptor (GLP-1) agonists are potentially beneficial for stroke risk in patients with T2D.

View

Conditions

Category

  • icon
  • icon
  • icon
  • icon
  • icon
  • icon
  • icon
  • icon
  • icon

Was this helpful?